USCWA
PCRX icon

U.S. Capital Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$38.6K – 1258
2022
Q4 		$38.6K Buy
+1,000
New +$38.6K ﹤0.01% 942